Concepedia

Jenny Kreahling

JK

11

Publications

605

Citations

11

H-Index

2000

Active since

Affiliations

Moffitt Cancer Center(Current)

University of South Florida

Jenny Kreahling is an author at Moffitt Cancer Center specializing in medicine, oncology, and tumor biology.

Top concepts

Publications per year

2000–2017

11

Publications

11

MK1775, a Selective Wee1 Inhibitor, Shows Single-Agent Antitumor Activity against Sarcoma Cells

Jenny Kreahling, Jennifer Gemmer, Damon R. Reed et al. · Molecular Cancer Therapeutics · 2011 · 122 citations · Full text

, , +14

Wee1 Inhibition by MK-1775 Leads to Tumor Inhibition and Enhances Efficacy of Gemcitabine in Human Sarcomas

Jenny Kreahling, Parastou Foroutan, Damon R. Reed et al. · PLoS ONE · 2013 · 89 citations · Full text

Identification of Synergistic, Clinically Achievable, Combination Therapies for Osteosarcoma

Diana Yu, Elliot Kahen, Christopher Cubitt et al. · Scientific Reports · 2015 · 71 citations · Full text

, , +14

Histone Deacetylase Inhibitors Downregulate Checkpoint Kinase 1 Expression to Induce Cell Death in Non-Small Cell Lung Cancer Cells

William Brazelle, Jenny Kreahling, Jennifer Gemmer et al. · PLoS ONE · 2010 · 68 citations · Full text

A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors

Jhanelle E. Gray, Eric B. Haura, Alberto Chiappori et al. · Clinical Cancer Research · 2014 · 58 citations · Full text

Rows per page

1–5 of 11